Friday, November 13, 2026

Greece Bailout Green Light From Eurozone but Not IMF

The Eurogroup approved Greece's third bailout package of €86 billion on August 14, 2015. Greek Finance Minister Euclid Tsakalotos confirmed depositors' money would be protected from bail-in, while the IMF maintained that Greek debt remains "highly unsustainable."

LM Salvado
LM Salvado

August 15, 2015

Euro - Image credits Mick Carvalho
On Friday, August 14, 2015, the Eurogroup agreed to the third Greece rescue package of € 86 billion ($ 95.5 billion). The 3-year bailout first tranche of € 26 billion ($ 28.9) will be used to repay debt and recapitalize the banking system. According to the Greek Finance Minister Euclid Tsakalotos, a depositors money bail-in is out of the question. The Eurogroup president, Jeroen Dijsselbloem said at the press conference that "the Eurogroup have come to a positive conclusion" and that "All the intense work over the last week has paid off." In the same press conference Jeroen Dijsselbloem mentioned the IMF by saying:

We welcome the intention of the IMF board to consider further financial support to Greece. They will do so in the autumn. We stressed that such IMF involvement for the Eurogroup is indispensable, and we welcome the positive assessment of the IMF staff of the policy conditionality contained in the MOU (Memorandum of Understanding). For the IMF board to consider further financial support there are two crucial issues, we realize and accept that. First, there needs to be a full specification of fiscal structural and financial system reforms and secondly that debt sustainability is ensured.

Jeroen Dijsselbloem

The Greek depositors' money is safe

Some EU Finance Ministers made it clear that deposits are safe, discarding any panic depositors may have had regarding losing their savings. Leaving the Eurogroup Meeting, the Greek Finance Minister Euclid Tsakalotos confirmed that no deposit bail-in would take place.
"This deal is something that we hope will take Greece forward. It takes Greece forward in the sense that the financial system should be much more stable from now on. There is the promise of the recapitalization of the banks without any deposit having any bail-in or anything to worry about. The process of reversing the negative effects of capital controls will start very quickly and will speedily return the banks to where they were before and hopefully on a far firmer footing."

Euclid Tsakalotos (Greek Finance Minister)

The IMF still considers the Greek debt unsustainable

In an IMF statement issued Friday night by Christine Lagarde, the Greek's public debt is "highly unsustainable" and the bailout should include measures to restructure the country's debt. The "European partners should make commitments to relieve Greek debt, well beyond what has been done so far". Christine Lagarde added that only after a Greek debt relief will it be possible to implement a credible and comprehensive program for Greece. Only then will the IMF Board of Directors provide more financial assistance to help Greece.
LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com